Responses
Therapeutics
Randomised controlled trial
Combined prophylactic β-blocker and behavioural migraine management improves 30-day migraine outcomes compared with either strategy alone, or optimised acute treatment only
Compose a Response to This Article
Other responses
No responses have been published for this article.